会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明公开
    • 리포테이코익산 유래 당지질 및 이를 포함하는 조성물
    • 来自左旋酸的甘油和包含它的组合物
    • KR1020110021699A
    • 2011-03-04
    • KR1020100083196
    • 2010-08-26
    • 주식회사 알엔에이
    • 정대균장경순김병기김한근김나라이혜영정봉준김태락정지혜
    • C07H15/203C07H15/04C07H11/04A61P35/00
    • C07H13/06C07H11/04C07H15/04
    • PURPOSE: A lipoteichoic acid-derived glycolipid and pharmaceutical, food, and cosmetic composition are provided to ensure anti-inflammation effect by suppressing inflammatory cytokine. CONSTITUTION: A lipoteichoic acid-derived glycolipid contains 2-6 saturated or unsaturated acyl chain of C10-C30 at one site of C1, C3, C4 and C6 site of double or triple hexose. The glycolipid has a structure of chemical formula I. Bacteria includes Lactobacillus, Bifidobacterium, Streptococcus, or Lactococcus. The glycolipid is additionally bound with polyphosphoric acid glycerol at C6 site of hexose in which an acyl chain is not bound. A pharmaceutical composition for preventing and treating inflammatory diseases or immune diseases contains lipoteichoic acid-derived glycolipid and additionally contains antibiotics, carrier, excipient, or diluents. The pharmaceutical composition is manufactured in the form of powder, granule, tablet, capsule, suspension, emulsion, syrup, suppository, or sterilized injection.
    • 目的:提供脂磷壁酸糖脂和药物,食品和化妆品组合物,以通过抑制炎症细胞因子来确保抗炎作用。 构成:脂磷壁酸的糖脂在双或三己糖的C1,C3,C4和C6位点的一个位点含有2-6个饱和或不饱和的C10-C30酰基链。 该糖脂具有化学式I的结构。细菌包括乳杆菌属,双歧杆菌属,链球菌属或乳球菌属。 该糖脂在己糖的C6位点处另外与多磷酸甘油结合,其中酰基链未被结合。 用于预防和治疗炎性疾病或免疫疾病的药物组合物含有脂磷壁酸衍生的糖脂,另外含有抗生素,载体,赋形剂或稀释剂。 药物组合物以粉末,颗粒,片剂,胶囊,悬浮液,乳剂,糖浆,栓剂或灭菌注射剂的形式制备。